Raia Drogasil S.A. (OTCMKTS:RADLY) Short Interest Down 95.3% in April

Raia Drogasil S.A. (OTCMKTS:RADLY) was the recipient of a significant decline in short interest in the month of April. As of April 30th, there was short interest totaling 1,032 shares, a decline of 95.3% from the April 15th total of 21,996 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily trading volume, of 19,994 shares, the short-interest ratio is currently 0.1 days.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised Raia Drogasil to a “hold” rating in a research note on Thursday, April 9th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat, Raia Drogasil has a consensus rating of “Hold”.

Raia Drogasil Price Performance

Shares of OTCMKTS:RADLY remained flat at $4.22 on Wednesday. The company’s stock had a trading volume of 5,135 shares, compared to its average volume of 17,989. The company has a fifty day moving average of $4.57 and a 200-day moving average of $4.52. Raia Drogasil has a 12 month low of $2.17 and a 12 month high of $5.34.

About Raia Drogasil

Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.

The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.